Read More Pharma Industry News Lupin (NSE: LUPIN) goes big in the U.S.—$250m Coral Springs facility sparks investor buzz Find out how Lupin’s $250 million Coral Springs manufacturing facility could redefine America’s respiratory drug security and boost U.S. pharma resilience. byVenkateshOctober 9, 2025